GTA-Glyceryltriacetate for Canavan Disease

Clinical trial NCT00278707 · UNKNOWN

Trial details

NCT number: NCT00278707
Sponsor: Sheba Medical Center
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Infantile Canavan Disease Deficiency Disease, Aspartoacylase

Start date: 2006-01-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.